Month 12: Quarterly technical progress reports detailing technical progress made, tasks accomplished, major risks/mitigations, a technical plan for the remainder of Phase II Base Period (with necessary updates as in the parenthetical remark for Months 3, 5, and 7), planned activities, trip summaries, and any potential issues or problem areas that require the attention of the DARPA PM
Patients who attempt this without guidance risk plateauing or misusing the medication
Maintaining adequate levels can help reduce the mortality risk associated with these conditions
All three medications reduce triglycerides, but retatrutide produces the largest reductions, likely because of the glucagon-driven increase in fat oxidation
If you have any questions about how long your supply of retatrutide can be stored, contact your clinical trial coordinator, the dispensing pharmacy, or your supervising healthcare professional directly
The effect of gemcitabine on cell cycle arrest and microRNA signatures in pancreatic cancer cells